Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep970 | Thyroid | ECE2024

Case report: nivolumab induced dual hypophysitis and secondary hyperthyroidism

Worby Geraint , Cole Brittany , Tan Mae , Qazi Umer

A gentleman in his 70s with a background of atrial fibrillation, hypertension, and mesothelioma undergoing immunotherapy via Nivolumab and Ipilimumab, presented with general unwellness, fevers, confusion, and headaches. He had no prior endocrine history but was found to have significantly deranged thyroid function tests. He was treated for thyrotoxicosis and an impending thyroid storm with carbimazole. He remained treatment resistant for several days, with continuous delirium,...